共 9 条
[1]
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Shepherd J,Blauw GJ,Murphy MB,et al. The Lancet . 2002
[2]
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomise. Sever PS,Dahlof B,Poulter NR,et al. The Lancet . 2003
[3]
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial[J] .  The Lancet . 2003 (9364)
[4]
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Downs JR,Clearfield M,Whitney E,et al. The Journal of The American Medical Association . 1998
[5]
A tale of coronary artery disease and myocardial infarction. NABEL E G,BRAUNWALD E. The New England Journal of Medicine . 2012
[6]
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease:meta-analysis of individual data from 27 randomised trials. MIHAYLOVA B,EMBERSON J,et al. The Lancet . 2012
[7]
2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. European Society of Hypertension-European of Cardiology Guidelines Committee. Journal of Hypertension . 2003
[8]
Effect of LongTerm Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease:A Mendelian Randomization Analysis. FERENCE B A,YOO W,ALESH I,et al. Journal of the American College of Cardiology . 2012
[9]
Design of the Collaborative Atorvastatin Diabetes Study (CARDS) in patients with type 2 diabetes. Colhoun HM,Thomason MJ,Mackness MI,et al. Diabetic Medicine . 2002